First human trial tests partial reprogramming to reverse aging in glaucoma
TL;DR Summary
Scientists have treated the first participant in an early-stage clinical trial testing partial cellular reprogramming to make aging cells act younger, aiming to regenerate optic nerve neurons in glaucoma. While promising, the approach is experimental, enrolling up to 12 participants, with potential cancer risk, and is not a universal anti-aging therapy.
- Scientists begin first trial to reverse human aging Yahoo
- Turning Back the (Biological) Clock theSkimm
- Scientists test first-ever therapy to make human cells young again NewsNation
- First ‘cell rejuvenation’ therapy in humans: Can ageing finally be treated? The Times of India
- Longevity Science Splits Between Promising Research and “Miracle” Claims tovima.com
Reading Insights
Total Reads
1
Unique Readers
6
Time Saved
45 min
vs 46 min read
Condensed
99%
9,130 → 51 words
Want the full story? Read the original article
Read on Yahoo